RecruitingNot ApplicableNCT05200923
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
Sponsor
MedtronicNeuro
Enrollment
300 participants
Start Date
Jan 18, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
To collect physiological signals at several timepoints during the therapy evaluation period.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Sacral Neuromodulation for people with fecal incontinence, overactive bladder, and other related conditions. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICESacral Neuromodulation
Sacral neuromodulation delivers electrical stimulation to a sacral nerve
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05200923
Related Trials
Consumer Evaluation of an Investigational Intermittent Catheter
NCT077146941 location
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NCT0651114121 locations
Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence
NCT0497615334 locations
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
NCT048730371 location
Rectus Abdominis Detrusor Myoplasty for Urinary Retention
NCT073798141 location